List of Axikin Pharmaceuticals patents

Patents where

Current Assignee

Name

Axikin Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders	Patent 7674797 was granted and assigned to Axikin Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	7674797	March 9, 2010
‌ US Patent 9346792 3,5-diaminopyrazole kinase inhibitors	Patent 9346792 was granted and assigned to Axikin Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9346792	May 24, 2016
‌ US Patent 7829685 Regulation of kinase, regulated in COPD kinase (RC kinase)	Patent 7829685 was granted and assigned to Axikin Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	7829685	November 9, 2010
‌ US Patent 9637460 Isotopically enriched arylsulfonamide CCR3 antagonists	Patent 9637460 was granted and assigned to Axikin Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9637460	May 2, 2017
‌ US Patent 8741894 Arylsulfonamide CCR3 antagonists	Patent 8741894 was granted and assigned to Axikin Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	8741894	June 3, 2014
‌ US Patent 8669247 2,5-disubstituted arylsulfonamide CCR3 antagonists	Patent 8669247 was granted and assigned to Axikin Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	8669247	March 11, 2014
‌ US Patent 8399456 2,5-disubstituted arylsulfonamide CCR3 antagonists	Patent 8399456 was granted and assigned to Axikin Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	8399456	March 19, 2013
‌ US Patent 8999995 Isotopically enriched arylsulfonamide CCR3 antagonists	Patent 8999995 was granted and assigned to Axikin Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	8999995	April 7, 2015
‌ US Patent 9156799 Isotopically enriched arylsulfonamide CCR3 antagonists	Patent 9156799 was granted and assigned to Axikin Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9156799	October 13, 2015
‌ US Patent 8420639 Arylsulfonamide CCR3 antagonists	Patent 8420639 was granted and assigned to Axikin Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	8420639	April 16, 2013
‌ US Patent 9206186 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders	Patent 9206186 was granted and assigned to Axikin Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9206186	December 8, 2015
‌ US Patent 9187425 2,5-disubstituted arylsulfonamide CCR3 antagonists	Patent 9187425 was granted and assigned to Axikin Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9187425	November 17, 2015
‌ US Patent 9546163 3,5-diaminopyrazole kinase inhibitors	Patent 9546163 was granted and assigned to Axikin Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9546163	January 17, 2017
‌ US Patent 9365556 3,5-diaminopyrazole kinase inhibitors	Patent 9365556 was granted and assigned to Axikin Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9365556	June 14, 2016
‌ US Patent 9382237 3,5-diaminopyrazole kinase inhibitors	Patent 9382237 was granted and assigned to Axikin Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9382237	July 5, 2016
‌ US Patent 9540351 Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors	Patent 9540351 was granted and assigned to Axikin Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	9540351	January 10, 2017
‌ US Patent 8658642 Arylsulfonamide CCR3 antagonists	Patent 8658642 was granted and assigned to Axikin Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	8658642	February 25, 2014
‌ US Patent 8916555 3,5-diaminopyrazole kinase inhibitors		Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	8916555	December 23, 2014
‌ US Patent 7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders	Patent 7700586 was granted and assigned to Axikin Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	7700586	April 20, 2010
‌ US Patent 8563544 2,5-disubstituted arylsulfonamide CCR3 antagonists	Patent 8563544 was granted and assigned to Axikin Pharmaceuticals on October, 2013 by the United States Patent and Trademark Office.	Axikin Pharmaceuticals	Axikin Pharmaceuticals	United States Patent and Trademark Office	8563544	October 22, 2013
‌ US Patent 8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders	Patent 8242118 was granted and assigned to Axikin Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office.		Axikin Pharmaceuticals	United States Patent and Trademark Office	8242118	August 14, 2012
‌ US Patent 8318747 2,5-disubstituted arylsulfonamide CCR3 antagonists			Axikin Pharmaceuticals	United States Patent and Trademark Office	8318747	November 27, 2012

22 results

0 selected

22 results

0 selected